Literature DB >> 9519163

Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum.

A J Humberstone1, A F Cowman, J Horton, W N Charman.   

Abstract

Halofantrine (Hf) is a highly lipophilic antimalarial which significantly associates with triglyceride (TG) rich plasma lipoproteins, and this is likely manifest as a decrease in the free fraction of drug. This study assessed the effect of using growth media containing 10% serum containing different concentrations of TG (i.e. TG-rich plasma lipoproteins) on the IC50 of Hf determined using continuous in vitro culture of Plasmodium falciparum. Serum was collected from a human subject in either a fasted state or at various times after ingestion of a fatty meal. There was a linear and statistically significant 2.5-fold increase in the IC50 of Hf across a 6-fold range of increasing TG concentrations, with the increased IC50 values being ascribed to a decreased free fraction of Hf in the growth media due to sequestration by TG-rich lipoproteins. Chloroquine diphosphate, which is hydrophilic and not significantly bound by TG-rich lipoproteins, was used as a control and its IC50 values were independent of TG concentrations. These data indicate that consideration should be given to the adoption of standard conditions for the collection of serum with respect to pre- or postprandial states, and that subject- and disease-related factors which alter plasma lipoprotein profiles should be considered when interpreting the IC50 profile of Hf (and possibly other lipophilic antimalarials). Furthermore, although food is known to affect the pharmacokinetics of Hf, these data suggest that altered plasma lipoprotein profiles could also influence its pharmacodynamic profile.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519163     DOI: 10.1021/js970279q

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics.

Authors:  Mohamad Firas Bassissi; Michel Alvinerie; Pascal Guy Pierre Martin; Bertrand Perret; Anne Lespine
Journal:  Pharm Res       Date:  2006-09-15       Impact factor: 4.200

2.  The stereoselective distribution of halofantrine enantiomers within human, dog, and rat plasma lipoproteins.

Authors:  D R Brocks; M Ramaswamy; A I MacInnes; K M Wasan
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Association of Lipid Levels with Mefloquine and Carboxy-Mefloquine Concentrations in Patients with Uncomplicated Falciparum Malaria.

Authors:  José Luiz Fernandes Vieira; Juan Gonzalo Bardalez Rivera; Luann Wendel Pereira de Sena; Michelle Valeria Dias Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding.

Authors:  P Aviles; C Falcoz; M J Guillén; R San Roman; F Gómez De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.

Authors:  B R Moore; J M Benjamin; S Salman; S Griffin; E Ginny; M Page-Sharp; L J Robinson; P Siba; K T Batty; I Mueller; T M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

6.  Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats.

Authors:  Jigar P Patel; Dion R Brocks
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

7.  In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera.

Authors:  P Ringwald; F S Meche; J Bickii; L K Basco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.

Authors:  Kesinee Chotivanich; Mathirut Mungthin; Ronnatrai Ruengweerayuth; Rachanee Udomsangpetch; Arjen M Dondorp; Pratap Singhasivanon; Sasithon Pukrittayakamee; Nicholas J White
Journal:  Malar J       Date:  2012-05-28       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.